Literature DB >> 32783917

The In Situ Structure of Parkinson's Disease-Linked LRRK2.

Reika Watanabe1, Robert Buschauer1, Jan Böhning1, Martina Audagnotto1, Keren Lasker2, Tsan-Wen Lu3, Daniela Boassa4, Susan Taylor5, Elizabeth Villa6.   

Abstract

Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most frequent cause of familial Parkinson's disease. LRRK2 is a multi-domain protein containing a kinase and GTPase. Using correlative light and electron microscopy, in situ cryo-electron tomography, and subtomogram analysis, we reveal a 14-Å structure of LRRK2 bearing a pathogenic mutation that oligomerizes as a right-handed double helix around microtubules, which are left-handed. Using integrative modeling, we determine the architecture of LRRK2, showing that the GTPase and kinase are in close proximity, with the GTPase closer to the microtubule surface, whereas the kinase is exposed to the cytoplasm. We identify two oligomerization interfaces mediated by non-catalytic domains. Mutation of one of these abolishes LRRK2 microtubule-association. Our work demonstrates the power of cryo-electron tomography to generate models of previously unsolved structures in their cellular environment.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Parkinson's disease; correlative light and electron microscopy; cryo-electron tomography; integrative modeling; kinase; leucine-rich repeat kinase; microtubule; subtomogram analysis

Mesh:

Substances:

Year:  2020        PMID: 32783917      PMCID: PMC7869717          DOI: 10.1016/j.cell.2020.08.004

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  85 in total

1.  The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules.

Authors:  Payal N Gandhi; Xinglong Wang; Xiongwei Zhu; Shu G Chen; Amy L Wilson-Delfosse
Journal:  J Neurosci Res       Date:  2008-06       Impact factor: 4.164

2.  Structure and nucleotide-induced conformational dynamics of the Chlorobium tepidum Roco protein.

Authors:  Egon Deyaert; Margaux Leemans; Ranjan Kumar Singh; Rodrigo Gallardo; Jan Steyaert; Arjan Kortholt; Janelle Lauer; Wim Versées
Journal:  Biochem J       Date:  2019-01-07       Impact factor: 3.857

3.  Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity.

Authors:  Jack D Scott; Duane E DeMong; Thomas J Greshock; Kallol Basu; Xing Dai; Joel Harris; Alan Hruza; Sarah W Li; Sue-Ing Lin; Hong Liu; Megan K Macala; Zhiyong Hu; Hong Mei; Honglu Zhang; Paul Walsh; Marc Poirier; Zhi-Cai Shi; Li Xiao; Gautam Agnihotri; Marco A S Baptista; John Columbus; Matthew J Fell; Lynn A Hyde; Reshma Kuvelkar; Yinghui Lin; Christian Mirescu; John A Morrow; Zhizhang Yin; Xiaoping Zhang; Xiaoping Zhou; Ronald K Chang; Mark W Embrey; John M Sanders; Heather E Tiscia; Robert E Drolet; Jonathan T Kern; Sylvie M Sur; John J Renger; Mark T Bilodeau; Matthew E Kennedy; Eric M Parker; Andrew W Stamford; Ravi Nargund; John A McCauley; Michael W Miller
Journal:  J Med Chem       Date:  2017-03-16       Impact factor: 7.446

4.  Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations.

Authors:  Bernd K Gilsbach; Franz Y Ho; Ingrid R Vetter; Peter J M van Haastert; Alfred Wittinghofer; Arjan Kortholt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

5.  MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition.

Authors:  Matthew J Fell; Christian Mirescu; Kallol Basu; Boonlert Cheewatrakoolpong; Duane E DeMong; J Michael Ellis; Lynn A Hyde; Yinghui Lin; Carrie G Markgraf; Hong Mei; Michael Miller; Frederique M Poulet; Jack D Scott; Michelle D Smith; Zhizhang Yin; Xiaoping Zhou; Eric M Parker; Matthew E Kennedy; John A Morrow
Journal:  J Pharmacol Exp Ther       Date:  2015-09-25       Impact factor: 4.030

6.  LRRK2 activation in idiopathic Parkinson's disease.

Authors:  Roberto Di Maio; Eric K Hoffman; Emily M Rocha; Matthew T Keeney; Laurie H Sanders; Briana R De Miranda; Alevtina Zharikov; Amber Van Laar; Antonia F Stepan; Thomas A Lanz; Julia K Kofler; Edward A Burton; Dario R Alessi; Teresa G Hastings; J Timothy Greenamyre
Journal:  Sci Transl Med       Date:  2018-07-25       Impact factor: 17.956

7.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs.

Authors:  Alexis Rohou; Nikolaus Grigorieff
Journal:  J Struct Biol       Date:  2015-08-13       Impact factor: 2.867

8.  A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan.

Authors:  Hon-Chung Fung; Chiung-Mei Chen; John Hardy; Andrew B Singleton; Yih-Ru Wu
Journal:  BMC Neurol       Date:  2006-12-22       Impact factor: 2.474

Review 9.  A microtubule bestiary: structural diversity in tubulin polymers.

Authors:  Sami Chaaban; Gary J Brouhard
Journal:  Mol Biol Cell       Date:  2017-11-01       Impact factor: 4.138

10.  Multi-particle cryo-EM refinement with M visualizes ribosome-antibiotic complex at 3.5 Å in cells.

Authors:  Dimitry Tegunov; Liang Xue; Christian Dienemann; Patrick Cramer; Julia Mahamid
Journal:  Nat Methods       Date:  2021-02-04       Impact factor: 28.547

View more
  40 in total

1.  The secret lives of cells - as never seen before.

Authors:  Diana Kwon
Journal:  Nature       Date:  2021-10       Impact factor: 49.962

2.  Ciliary central apparatus structure reveals mechanisms of microtubule patterning.

Authors:  Miao Gui; Xiangli Wang; Susan K Dutcher; Alan Brown; Rui Zhang
Journal:  Nat Struct Mol Biol       Date:  2022-05-16       Impact factor: 18.361

Review 3.  High-resolution in situ structure determination by cryo-electron tomography and subtomogram averaging using emClarity.

Authors:  Tao Ni; Thomas Frosio; Luiza Mendonça; Yuewen Sheng; Daniel Clare; Benjamin A Himes; Peijun Zhang
Journal:  Nat Protoc       Date:  2022-01-12       Impact factor: 17.021

Review 4.  Label-free visual proteomics: Coupling MS- and EM-based approaches in structural biology.

Authors:  Oleg Klykov; Mykhailo Kopylov; Bridget Carragher; Albert J R Heck; Alex J Noble; Richard A Scheltema
Journal:  Mol Cell       Date:  2022-01-20       Impact factor: 17.970

5.  Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2.

Authors:  Sven H Schmidt; Jui-Hung Weng; Phillip C Aoto; Daniela Boassa; Sebastian Mathea; Steve Silletti; Junru Hu; Maximilian Wallbott; Elizabeth A Komives; Stefan Knapp; Friedrich W Herberg; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 12.779

6.  Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomes.

Authors:  C Alexander Boecker; Juliet Goldsmith; Dan Dou; Gregory G Cajka; Erika L F Holzbaur
Journal:  Curr Biol       Date:  2021-03-24       Impact factor: 10.900

Review 7.  Allosteric inhibition of LRRK2, where are we now.

Authors:  Ahmed Soliman; Fatma Nihan Cankara; Arjan Kortholt
Journal:  Biochem Soc Trans       Date:  2020-10-30       Impact factor: 5.407

Review 8.  The 14-3-3 Proteins as Important Allosteric Regulators of Protein Kinases.

Authors:  Veronika Obsilova; Tomas Obsil
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

9.  The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo.

Authors:  Noémie Cresto; Camille Gardier; Marie-Claude Gaillard; Francesco Gubinelli; Pauline Roost; Daniela Molina; Charlène Josephine; Noëlle Dufour; Gwenaëlle Auregan; Martine Guillermier; Suéva Bernier; Caroline Jan; Pauline Gipchtein; Philippe Hantraye; Marie-Christine Chartier-Harlin; Gilles Bonvento; Nadja Van Camp; Jean-Marc Taymans; Karine Cambon; Géraldine Liot; Alexis-Pierre Bemelmans; Emmanuel Brouillet
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

10.  Structural analysis of the full-length human LRRK2.

Authors:  Alexander Myasnikov; Hanwen Zhu; Patricia Hixson; Boer Xie; Kaiwen Yu; Aaron Pitre; Junmin Peng; Ji Sun
Journal:  Cell       Date:  2021-06-08       Impact factor: 66.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.